(Reuters) - After a nationwide
meningitis outbreak was tied to drugs shipped from a plant
in Massachusetts, the
state is requiring all pharmacy compounders to sign a statement saying
they are complying with regulations on their work, officials said on
Wednesday.
The Massachusetts Department of Public Health
also confirmed that compounder Ameridose LLC has agreed to close
temporarily. Ameridose shares ownership with the New England Compounding Center that shipped
thousands of vials of steroid drugs linked to the meningitis
outbreak.
The actions follow concerns that NECC and other
compounding pharmacies, which produce custom-made versions of medications for
doctors, hospitals and clinics, have violated laws that allow them to alter
drugs based on the needs of individual patients rather than produce large
batches of medication for sale. To continue reading click here
No comments:
Post a Comment